bearish

Teladoc Health, Inc.

Teladoc Health Inc (TDOC US): 1Q22 Results Review- Revenue Missed, 2022 Guidance Reduced

Teladoc has reduced 2022 guidance due to unfavorable market dynamics, which will limit near-term upside potential of the shares. Long-term fundamental growth story remains intact.

Equity Bottom-Up
205 Views, 28 Apr 2022 16:51
SUMMARY
or

Discussions
(Paid Plans Only)
WHAT’S TRENDING
Insights
  • Trending
  • Latest
Logo
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Health CareEquity Bottom-UpThematic (Sector/Industry)

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare compa... 

Price Chart(Sign Up to Access)
analytics-chart
x